TrialThe oncologist2021

A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11).

Li Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.